Sen. John Braun’s Political Contributions and Stance on Health Care Legislation
Senator John Braun from Washington has been a notable recipient of donations from both the pharmaceutical and health insurance industries throughout his political tenure. His voting record shows opposition to initiatives aimed at reducing health care expenses.
Braun is currently campaigning for a seat in the U.S. House representing Washington’s 3rd District, a position presently held by Democratic Representative Marie Gluesenkamp Perez.
According to campaign finance data, Braun has amassed $73,550 from pharmaceutical corporations and $37,400 from health insurance companies since 2012. Contributions from these sectors make up approximately 10% of his total donations.
In 2022, Braun aligned with pharmaceutical interests by opposing a bipartisan initiative to establish Washington’s Prescription Drug Affordability Board. This board is designed to assess the costs of specific medications and has the authority to cap what individuals, state bodies, and insurers pay. The AARP supports the board, suggesting it “could lead to lower insurance premiums, reduce taxpayer spending on health care, and would help ensure people can afford the medication they need.” However, the initiative has faced criticism from PhRMA, a pharmaceutical trade group that contributed to Braun’s campaign in 2015 and 2016.
In the preceding year, Braun also opposed legislation that would permit Washington to purchase, manufacture, and distribute generic drugs, which are often cheaper alternatives to brand-name medications.
In 2020, Braun voted against a bill that would allow the state to bulk-buy insulin, making it available to patients at a discounted price. He also rejected a proposal mandating that health insurers in Washington cover pre-existing conditions.
Despite these positions, Braun claims that his primary focus is on affordability and cost reduction. In June, he criticized Gluesenkamp Perez for opposing what he described as “the largest tax cut in history,” a measure that largely benefits wealthier individuals and comes with a $1 trillion reduction in Medicaid funding.
Health care affordability is anticipated to be a pivotal issue in the 2026 electoral race. A June 2026 Gallup poll revealed that the capacity of Americans to afford health care has hit a five-year low.
President Donald Trump has endorsed Braun’s campaign.
—
Read More Kitchen Table News
